Cancer
Programmable 3D printed wound dressing could improve treatment for burn, cancer patients
One of the challenges in treating burn victims is the frequency of dressing changes, which can be extremely painful. Credit: University...
BORIS gene mutation and expression: Link to breast cancer progression
“The current study analyzed the correlation between BORIS mutations and the expression of the protein in breast cancer cases.”Credit: 2023...
Pumping the brakes on autoimmune disease
LA JOLLA, CALIF. – June 5, 2023 – Researchers at Sanford Burnham Prebys, collaborating with scientists from Eli Lilly and...
Cancer discoveries could enhance immunotherapy, breast cancer care
Two new discoveries from the Dudley lab at UVA Cancer Center highlight the different roles of blood vessels in solid tumors –...
ASCO: Targeted therapy achieves responses across multiple cancer types with FGFR alterations
ABSTRACTS: 3121, 4504, LBA4619Credit: MD Anderson Cancer Center ABSTRACTS: 3121, 4504, LBA4619 CHICAGO ― Three clinical trials led by researchers...
ASCO: HER2-targeted antibody drug conjugate shows strong anti-tumor activity and durable responses across multiple tumor types
In a new study of trastuzumab deruxtecan, a HER2-targeted antibody drug conjugate, researchers observed encouraging responses and long-lasting clinical benefit...
Phase 3 SWOG Cancer Research Network trial, led by a City of Hope researcher, demonstrates one-year progression-free survival in 94% of patients with Stage 3 or 4 classic Hodgkin lymphoma who received a checkpoint inhibitor combined with chemotherapy
LOS ANGELES and PORTLAND, Ore. — A Phase 3 trial has demonstrated that patients with advanced stage (3 or 4) classic Hodgkin lymphoma who...
The promise of novel FolRα-targeting antibody drug conjugate in recurrent epithelial ovarian cancer
Credit: Vall d'Hebron Institute of Oncology (VHIO). Presented today by VHIO’s Ana Oaknin at the 2023 ASCO Annual Meeting, 2-6...
ASCO: Targeted therapy induces responses in HER2-amplified biliary tract cancer
ABSTRACT: 4008Credit: MD Anderson Cancer Center ABSTRACT: 4008 CHICAGO ― HER2-targeted bispecific antibody zanidatamab demonstrated durable responses in patients with...
For advanced, HER2-amplified bile duct cancers, antibody treatment trial shows promising results
Bile duct cancers are uncommon and aggressive types of gastrointestinal cancer. They include cholangiocarcinomas, which can form inside or outside of...
Results of SWOG S1929 trial show patients with small-cell lung cancer with SLFN11 expression can benefit from PARP inhibitor added to immune checkpoint blockade
Among patients with extensive stage small-cell lung cancer (SCLC) that is positive for expression of the Schlafen-11 gene (SLFN11), those...
Scientists reveal new details of cellular process which prevents spread of cancer
Researchers have for the first time characterised a unique molecular mechanism of the early stages of programmed cell death or apoptosis,...
ASCO 23: Thyroid cancer precision approaches that incorporate targeted therapies and other treatments are changing the surgeon’s role
DOWNLOADABLE B-ROLL/VIDEOCredit: Sylvester Comprehensive Cancer Center DOWNLOADABLE B-ROLL/VIDEO MIAMI, FLORIDA (June 1, 2023) – Historically, surgery was the first...
Owkin powers a new era in oncology research with MOSAIC – an unprecedented $50 million spatial atlas of cancer cells
– Cutting-edge spatial omics technologies to map cancer cells and their immune environment in high resolution, allowing AI to unlock...